An interventional study of Biofeedback and Inspiratory muscle training (IMT) in Dyssynergic Defecation and Constipation, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-11-10.
Sponsored by Mayo Clinic · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Constipation by Mayo Clinic — 4 open to participants now, 5 under way, none of them phase 3. Constipation · Mayo Clinic.
Among the 14 studies in Constipation by Mayo Clinic, this one has the largest planned enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2025, is one of 5 with no phase, and was the 14th registered.
1,051 studies on the registry are indexed under Constipation; 163 are open to participants now.
Browse Constipation studies →4 of the 14 studies in Constipation by Mayo Clinic are open now, in 1 country. Recruiting first, the newest first:
Mayo Clinic · Sites in United States
Ages 18–70
Mayo Clinic · Sites in United States
Ages 18–80 · Healthy volunteers
Mayo Clinic · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 99 Constipation studies recruiting now, 32 (32%) set no upper age limit and 52 (53%) stop at 75 or younger; 17 take children under 18; 28 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 4 1
First in 2003; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 75 across 889 interventional studies indexed under Constipation.
Median enrollment 52 across the 11 interventional studies, 39 across the 3 observational. Of the 8 that completed or were terminated, 7 (88%) have results posted.
This tab as a report to print or save as PDF → With an account.
Mayo Clinic is the lead sponsor of 3,272 studies on the registry; 672 are open to participants now.
Of its 452 completed or terminated interventional studies of FDA-regulated products, 322 (71%) have results posted.
1 of the studies in Constipation by Mayo Clinic that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06657001Mayo ClinicEnabling Microbiomics- Driven Personalized Nutrition | 2027-09 |
Add it to your calendar (.ics) → With an account.
Among the 14 studies in Constipation by Mayo Clinic, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this research is to better understand constipation and improve biofeedback treatments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects in the BFT Plus arm will participate in a minimum of 6 up to a maximum of 20 biofeedback sessions, with each session lasting approximately 60 minutes. In addition, subjects will engage in inspiratory muscle training (IMT) at home.
Behavioral: Biofeedback · Behavioral: Inspiratory muscle training (IMT)
Subjects in the BFT Plus arm will participate in a minimum of 6 up to a maximum of 20 biofeedback sessions, with each session lasting approximately 60 minutes.
Behavioral: Biofeedback
During anorectal biofeedback therapy, subjects are coached to improve abnormal patterns while observing activity recorded by manometry and/or surface EMG (electromyography) on a computer monitor while seated on a chair or a commode.
Subjects will engage in inspiratory muscle training (IMT) that is tailored to the baseline performance of the individual.
Change in rectoanal gradient during evacuation
Rectoanal gradient during evacuation is the pressure difference between the rectum and the anal canal during simulated evacuation, measured in millimeters of mercury (mmHg).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in rectal pressure during evacuation
Rectal pressure during evacuation is the difference in rectal pressure during - before evacuation. Results are measured in millimeters of mercury (mmHg).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in balloon expulsion time
Rectal balloon expulsion directly assesses evacuation. Patients will be asked to expel a rectal balloon inflated up to 50 ml of water. The time required to expel the balloon will be measured and reported in seconds.
Time frame: Baseline, through study completion, an average of 16 weeks
Change in rectal emptying time
Rectal emptying will be assessed via fecoflowmetry by measuring the time required to defecate (seconds) artificial stool from the rectum
Time frame: Baseline, through study completion, an average of 16 weeks
Change in rectal emptying rate
Rectal emptying will be assessed via fecoflowmetry by measuring the amount (gm) of artificial stool from the rectum. The 2 metrics - amount and time - are integrated to measure amount (gm) evacuated per unit time (second) (gm/sec).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in Patient Assessment of Constipation-Symptoms (PAC-SYM) questionnaire
The PAC-SYM questionnaire assesses the severity of patient-reported symptoms related to constipation. The questionnaire is divided into three symptom subscales: abdominal (four items); rectal (three items); and stool (five items). Items are scored on 5-point Likert scales, with scores ranging from 0 to 4 (0 = 'symptom absent', 1 = 'mild', 2 = 'moderate', 3 = 'severe' and 4 = 'very severe'). A mean total score in the range of 0-4 is generated by dividing the total score by the number of questions completed; the lower the total score, the lower the symptom burden. Scores range from 0 to 48.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Change in Patient Assessment of Constipation - Quality of Life (PAC-QOL) questionnaire
The PAC-QOL questionnaire is a patient-reported outcome measure to evaluate quality of life in constipated persons. The questionnaire is divided into four subscales: worries and concerns (11 items), physical discomfort (4 items), psychosocial discomfort (8 items), and satisfaction (5 items). Scale scores represent average item scores and range from 0 to 4, where higher scores represent poorer quality of life. Scores range from 0 to 112.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion , 12 months post completion
Physical Activity Rating Scale
Physical Activity Rating is a questionnaire for categorizing physical activity level, which is used in the equation for the non-exercise fitness test. The Physical Activity Rating is a score value between 0 to 7. The non-exercise fitness test of VO2max, a measure of cardiovascular fitness, will be calculated using the following equation: 56.363 + 1.921 (Physical Activity Rating) - 0.381(Age) - 0.754(Body Mass Index) + 10.987(Sex: 0 for women, 1 for men)
Time frame: Baseline
Quebec User Evaluation of Satisfaction with Assistive Technology questionnaire
Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST) 11-item questionnaire is a standardized tool to measure the satisfaction of an individual who is using an assistive device. It inquiries about the assistive device itself: dimensions, weight, ease of adjustment, safety, durability, ease of use, comfortability, and effectiveness; and service: service delivery, maintenance, professional services, and follow up services. Each question is answered on a Likert scale, where 1 = not satisfied at all, and 5 = very satisfied. Possible scores range from 11 to 55.
Time frame: through study completion, an average of 16 weeks
Change in stool frequency
Daily number of bowel movements will be self-reported by participants via a bowel diary.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Change in stool consistency
Daily stool consistency will be self-reported by participants via a bowel diary by using the Bristol Stool Chart. Participants will compare stool's appearance to the 7 types and selecting the one that most closely matches. Type 1-2 indicate constipation, Type 3-4 are ideal stools as they are easier to pass, and Type 5-7 may indicate diarrhea and urgency.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Change in anal digitation
The total number of times anal digitation was required to achieve a bowel movement will be self-reported via the bowel diary.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Change in sense of incomplete evacuation
The total number of times a participant felt a sense of incomplete evacuation after a bowel movement will be self-reported via the bowel diary.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Change in spontaneous bowel movements
The total number of times a participant achieves a spontaneous bowel movement will be self-reported via the bowel diary.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Change in pain during bowel movements
Pain during bowel movements will be self-reported by participants via the bowel diary using a 4-point Likert scale (0 = None, 1 = Mild, 3 = Moderate, and 4 = Severe).
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Change in bowel symptoms before and after biofeedback therapy
Bowel symptoms pre and post biofeedback therapy will be assessed using a self-reported questionnaire. The survey includes Severity of constipation, satisfaction with bowel movements, satisfaction with current treatment of constipation, severity of constipation compared to baseline, adequate relief of constipation, use of laxatives, and severity of abdominal bloating and distention. Impact of constipation on 15 QOL domains.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Change in Hospital Anxiety and Depression (HAD) score
The Hospital Anxiety and Depression (HAD) is a self-reported 14 item questionnaire asking participants to reflect on their mood in the past week. . Each item is rated on a 4-point scale, for a total score ranging from 0-21 for each subscale. A higher score indicates higher distress.
Time frame: Baseline, through study completion, an average of 16 weeks
Change in forced vital capacity
Forced vital capacity (FVC) is the the total volume of air exhaled with maximal effort, and is measured using a spirometer (reported in liters).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in forced expiratory volume
Forced expiratory volume (FEV) is the total volume of air exhaled with maximal effort, and is measured using a spirometer (reported in liters).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in forced expiratory time
Forced expiratory time (FET) is the time taken to exhale the greatest volume of air from the lungs as possible and is measured using a spirometer (reported in seconds).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in peak inspiratory flows
Peak inspiratory flow (PIF) is the maximum volume and rate of air that can be forcefully inhaled out of the lungs, and is measured using a spirometer (reported in liters per second (L/sec)).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in peak expiratory flows
Peak expiratory flow (PEF) is the maximum volume and rate of air that can be forcefully exhaled out of the lungs and is measured using a spirometer (reported in in liters per second (L/sec)).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in forced expiratory volume/forced vital capacity ratio
The total volume of air exhaled with maximal effort / The volume of air exhaled with maximum effort in the first second (reported as percentage).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in forced expiratory flow at 25-75% of forced vital capacity
The average flow from the point at which 25% of the forced vital capacity has been exhaled to the point at which 75% of the forced vital capacity has been exhaled. A reduced forced expiratory flow 25-75% is a marker of small airway obstruction.
Time frame: Baseline, through study completion, an average of 16 weeks
Change in forced expiratory flow at 50% of forced vital capacity
The flow rate at the point at which 50% point of the forced vital capacity has been exhaled, and is a marker of small airway obstruction.
Time frame: Baseline, through study completion, an average of 16 weeks
Change in forced inspiratory vital capacity
Forced inspiratory vital capacity is the maximum volume of air that can be inhaled after a full expiration (reported in liters).
Time frame: Baseline, through study completion, an average of 16 weeks
Change in peak inspiratory pressure
Peak inspiratory pressure is the peak pressure during forceful inspiration against an occluded airway (Mueller maneuver), reported in liters per minute (L/min)
Time frame: Baseline, through study completion, an average of 16 weeks
Change in peak expiratory pressure
Peak expiratory pressure is the peak pressure during forceful expiration against an occluded airway (Valsalva maneuver), reported in liters per minute (L/min)
Time frame: Baseline, through study completion, an average of 16 weeks
Plan to share: No
Started Jul 2025 (actual). Primary completion is estimated for Jul 2028, 36 months after the start.
Of 246 non-industry interventional studies with no phase under Constipation, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 35. This study's planned 36 months is above that.
Counting every sponsor, half of 317 studies reached it within 14 months; a quarter within 6 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.